Search Legislation

The Young Offender Institution Rules 2000

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

Changes over time for: The Young Offender Institution Rules 2000 (Schedules only)

 Help about opening options

Version Superseded: 26/10/2020

Status:

Point in time view as at 06/04/2020.

Changes to legislation:

There are currently no known outstanding effects for the The Young Offender Institution Rules 2000. Help about Changes to Legislation

Rule 89(1)

[F1Schedule 1] E+W REVOCATIONS

Rules RevokedS.I. number
The Young Offender Institution Rules 19881988/1422
The Young Offender Institution (Amendment) Rules 19891989/331
The Young Offender Institution (Amendment) (No. 2) Rules 19891989/2142
The Young Offender Institution (Amendment) Rules 19901990/1763
The Young Offender Institution (Amendment) Rules 19921992/513
The Young Offender Institution (Amendment) (No. 2) Rules 19921992/2081
The Young Offender Institution (Amendment) Rules 19931993/3076
The Young Offender Institution (Amendment) Rules 19941994/3194
The Young Offender Institution (Amendment) Rules 19951995/984
The Young Offender Institution (Amendment) (No. 2) Rules 19951995/1599
The Young Offender Institution (Amendment) Rules 19961996/1662
The Young Offender Institution (Amendment) Rules 19971997/789
The Young Offender Institution (Amendment) Rules 19981998/1545
The Young Offender Institution (Amendment) (No. 2) Rules 19991999/962
The Young Offender Institution (Amendment) Rules 20002000/700
The Young Offender Institution (Amendment) (No. 2) Rules 20002000/1795
The Young Offender Institution (Amendment) (No. 3) Rules 20002000/2642

Rule 2(1)

[F2SCHEDULE 2E+WDefinition of specified drug

(a)AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide);

(b)5F-AB-PINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(5-Fluoropentyl)-1H-indazole-3-carboxamide);

(c)AB-FUBINACA (N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide);

(d)APICA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide);

(e)5F-APICA (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide);

(f)APINACA (1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(g)5F-APINACA (1-(5-fluoropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide);

(h)5F-PB22 (1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid);

(i)MDMB-CHMICA (methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate);

(j)PB-22 (Quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate);

(k)5F-MDMB-PINACA (Methyl-[2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate]);

(l)AB-CHMINACA (N-[-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);

(m)5F-AMB (Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate);

(n)AMB-FUBINACA (Methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)-3-methylbutanoate);

(o)Etizolam (4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine);

(p)ADB-CHMINACA (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);

(q)MDMB-CHMCZCA (Methyl 2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate);

(r)EMB-FUBINACA (Ethyl 2-[[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3-methyl-butanoate);

(s)5F-Cumyl-PINACA (5-(5-fluoropentyl)-2-(1-methyl-1-phenylethyl)-pyrido[4,3-b]indol-1-one);

(t)THJ-018 (1-Naphthalenyl (1-pentyl-1H-indazol-3-yl)-methanone);

(u)Cumyl-PEGACLONE (2-(1-Methyl-1-phenyl-ethyl)-5-pentyl-pyrido[4,3-b]indol-1-one);

(v)Cumyl-PICA (1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide);

(w)Cumyl-THPINACA (N-(2-phenylpropan-2-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1-H-indazole-3-carboxamide;

(x)Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one);

(y)Nifoxipam 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one;

(z)Gabapentin - 1-(amino methyl)-cyclohexane acetic acid;

(z1)Pregabalin - (S)-3-(aminomethyl)-5-methylhexanoic acid;

(z2)Mirtazapine - 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine;

(z3)Amitriptyline - 3-(5,6-dihydrodibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine;

(z4)Quetiapine - (2-(2-(4-dibenzo [b,f][1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol);

(z5)Sertraline - (1S, 4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;

(z6)Citalopram - 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;

(z7)Venlafaxine - 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;

(z8)Carbamazepine – benzo[b][1]benzazepine-11-carboxamide;

(z9)Cetirizine - 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;

(z10)Chlorpromazine - 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine;

(z11)Fluoxetine N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;

(z12)Haloperidol - 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one;

(z13)Lamotrigine - 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine;

(z14)Naproxen - (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid;

(z15)Nefopam - 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine;

(z16)Olanzapine - 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine;

(z17)Paroxetine - (3S,4R)-3-[(1,3-benzodioxol-5-yloxymethyl]-4-(4-fluorophenyl)-piperidine;

(z18)Promethazine - N,N,α-Trimethyl-10H-phenothiazine-10-ethanamine;

(z19)Sildenafil - 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;

(z20)Trazodone - 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;

(z21)Varenicline -7,8,9,10-tetrahydro-6,10-methanol-6H-ptyrazine[2,3-h][3]benzapine;

(z22)Zopiclone - 6-(5-Chloro-2-pyridyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate;

(z23)Zuclopenthixol - 2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanoldihydrochloride.]

Back to top

Options/Help